Physician profile
Joseph Baust
NPI 1972598795
$848.70
in general payments reported to CMS, 2019-2025
16 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $17.13 · 2021: $18.60 · 2022: $67.26 · 2023: $173 · 2024: $56.64 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $147.13 | 2022-2024 | Azstarys |
| Pfizer INC. | $132.11 | 2019-2025 | |
| Kaleo, INC. | $103.58 | 2019-2023 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $59.66 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $58.54 | 2019 | |
| Glaxosmithkline, LLC. | $56.56 | 2023-2025 | Pediarix, Bexsero, Rotarix |
| Verrica Pharmaceuticals INC. | $41.07 | 2023-2024 | Ycanth |
| Sanofi Pasteur INC. | $38.20 | 2019-2023 | |
| Alk-Abello, INC | $37.58 | 2025 | Neffy |
| Arbor Pharmaceuticals, INC. | $37.42 | 2019 | |
| Tris Pharma INC | $30.46 | 2019 | |
| Merck Sharp & Dohme LLC | $26.61 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $25.24 | 2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $20.33 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $15.61 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Baust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.